Haymarket Medical has taken over the operations of two USHealthCare Communications oncology titles—The American Journal ofHematology/Oncology and Oncology Nursing News.

Haymarket Medical’s parent company owns MM&M. Terms ofthe deal were not disclosed.

Haymarket brought on two execs from Quadrant HealthCom torun it. Steven Svec, who was VP/group publisher at Quadrant, will serve aspublisher of the titles, and Chad Holloway, an associate publisher at Quadrant,will serve as sales director.

The American Journal of Hematology/Oncology remains amonthly, with a circulation of around 40,000 oncologists, hematology-oncologistsand sub-specialists, and will continue to be based in San Diego. OncologyNursing News will go down to a bimonthly schedule, with a circulation of around29,000, and will be moved into Haymarket’s New York offices.

Haymarket Medical CEO LeeManiscalco said: “The practical, clinical guidance these peer-reviewedpublications offer to their readers and the wide variety of continuingeducation opportunities they provide throughout the year make this a perfectfit for Haymarket.” It’s easy to see why Haymarket wants to play in theoncology space. The category was a rare bright spot in a bleak year for medicaljournals last year, with cancer therapies, the seventh-most heavily advertisedarea according to PERQ/HCI.